Zephyr Sciences

Zephyr AI is a healthcare technology company that combines high-resolution genomic data with advanced artificial intelligence to drive precision medicine. Originally founded as Zephyr Sciences, the company's platform integrates diverse data sources to discover novel drug targets, repurpose existing drugs, and predict patient responses to various therapies. Zephyr AI focuses primarily on oncology and cardiometabolic diseases, aiming to personalize treatment and improve patient outcomes. Through strategic partnerships with pharmaceutical companies like Janssen, Zephyr AI leverages its computational insights to accelerate drug development and clinical decision-making. The company is backed by prominent investors and is led by a team of experts in data science, biology, and healthcare policy.